U.S. Markets close in 5 hrs 32 mins

Medtronic To Face Class Action Suit From Canadian Users Of MiniMed Insulin Pumps

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • MDT
  • A national class action in Canada has been commenced against Medtronic Plc (NYSE: MDT) over its MiniMed 630G and 670G insulin pumps.

  • Rochon Genova and Cardill Law commenced the proposed class-action suit against Medtronic, Medtronic MiniMed, and Medtronic of Canada over the insulin pumps approved in Canada in 2016 and 2018.

  • Related Link: Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps.

  • For the same issue, missing or broken retainer rings that could result in the over-or under-delivery of insulin, Health Canada issued a Type II Medical Device Recall in 2019, then a Type 1 recall earlier this month.

  • The proposed class action alleges that Medtronic knew or ought to have known that the devices were suffering from a defective retainer ring but failed to take steps to address it or offer warnings to users.

  • The claims have not yet been proven in court.

  • Medtronic did not directly comment on the class action suit but referred to its October 5 news release covering the issue with the MiniMed 600 series devices.

  • Price Action: MDT shares are down 1.07% at $121.19 during the market session on the last check Thursday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.